Alps Advisors Inc Global Blood Therapeutics, Inc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $58,028 - $122,110	-1,791 Reduced 4.64%	36,829 $2.51 Million
Q2 2022 Aug 11, 2022	BUY	$22.3 - $37.39 $861,226 - $1.44 Million	38,620 New	38,620 $1.23 Million
Q4 2021 Feb 09, 2022	SELL	$24.9 - $40.26 $1.9 Million - $3.08 Million	-76,497 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$25.48 - $37.34 $127,756 - $187,222	-5,014 Reduced 6.15%	76,497 $1.95 Million
Q2 2021 Aug 11, 2021	SELL	$32.46 - $43.42 $983,018 - $1.31 Million	-30,284 Reduced 27.09%	81,511 $2.86 Million
Q1 2021 May 07, 2021	BUY	$38.94 - $50.85 $34,461 - $45,002	885 Added 0.8%	111,795 $4.56 Million
Q4 2020 Feb 03, 2021	BUY	$37.65 - $63.77 $1.23 Million - $2.08 Million	32,659 Added 41.74%	110,910 $4.8 Million
Q3 2020 Nov 04, 2020	SELL	$52.76 - $74.49 $257,310 - $363,287	-4,877 Reduced 5.87%	78,251 $4.32 Million
Q2 2020 Aug 05, 2020	SELL	$48.73 - $81.82 $1.27 Million - $2.14 Million	-26,109 Reduced 23.9%	83,128 $5.25 Million
Q1 2020 May 06, 2020	SELL	$41.72 - $87.2 $506,230 - $1.06 Million	-12,134 Reduced 10.0%	109,237 $5.58 Million
Q4 2019 Feb 07, 2020	BUY	$45.7 - $81.86 $79,061 - $141,617	1,730 Added 1.45%	121,371 $9.65 Million
Q3 2019 Nov 04, 2019	BUY	$45.35 - $57.91 $89,294 - $114,024	1,969 Added 1.67%	119,641 $5.81 Million
Q2 2019 Aug 07, 2019	SELL	$52.6 - $63.29 $865,322 - $1.04 Million	-16,451 Reduced 12.27%	117,672 $6.19 Million
Q1 2019 May 01, 2019	BUY	$39.99 - $53.48 $231,862 - $310,077	5,798 Added 4.52%	134,123 $7.1 Million
Q4 2018 Feb 04, 2019	BUY	$31.54 - $46.67 $1.14 Million - $1.69 Million	36,213 Added 39.31%	128,325 $5.27 Million
Q3 2018 Oct 25, 2018	BUY	$38.0 - $51.1 $661,048 - $888,935	17,396 Added 23.28%	92,112 $3.5 Million
Q2 2018 Aug 02, 2018	BUY	$38.7 - $50.15 $1.02 Million - $1.32 Million	26,293 Added 54.3%	74,716 $3.38 Million
Q2 2018 Jul 25, 2018	SELL	$38.7 - $50.15 $514,052 - $666,142	-13,283 Reduced 21.53%	48,423 $1.91 Million
Q1 2018 May 01, 2018	BUY	$39.6 - $65.9 $526,006 - $875,349	13,283 Added 27.43%	61,706 $2.98 Million
Q4 2017 Feb 05, 2018	BUY	$29.7 - $45.7 $160,617 - $247,145	5,408 Added 12.57%	48,423 $1.91 Million
Q3 2017 Nov 03, 2017	BUY	$25.1 - $31.05 $1.08 Million - $1.34 Million	43,015	43,015 $1.34 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account